Tag Archives: Boehringer Ingelheim

Health Care

Abu Dhabi Public Health Centre and Boehringer Ingelheim Partner to Combat Chronic Diseases in the UAE

Abu Dhabi, 16th May 2025: The Abu Dhabi Public Health Centre (ADPHC), an affiliate of the Department of Health – Abu Dhabi (DoH), has signed a Memorandum of Understanding (MoU) with Boehringer Ingelheim, a global leader in the pharmaceutical industry, to enhance health outcomes for patients living with chronic diseases in the Emirate.

The partnership aims to improve the quality of life for individuals affected by cardiovascular, renal, and metabolic (CRM) conditions, pulmonary fibrosis, and stroke. With non-communicable diseases (NCDs) on the rise across the UAE, this collaboration underscores the importance of joint, data-driven approaches to prevention, early detection, and public education.

Continue reading Abu Dhabi Public Health Centre and Boehringer Ingelheim Partner to Combat Chronic Diseases in the UAE →
Health Care

Dubai Miracle Garden Blooms with Hope as Boehringer Ingelheim Concludes Interstitial Lung Disease Awareness Campaign

  • Interstitial Lung Disease (ILD) is an umbrella term used for a large group of diseases that cause scarring (fibrosis) of the lungs. The scarring causes stiffness in the lungs which makes it difficult to breathe and get oxygen to the bloodstream.[i]
  • Boehringer Ingelheim, in collaboration with Emirates Thoracic Society (ETS) and social media influencer Ghaith Marwan, unveiled a breathtaking installation of lungs made from flowers at the Dubai Miracle Garden to raise awareness of the disease and highlight the importance of early diagnosis.
  • In the run-up to the event, a public social media campaign, led by Boehringer Ingelheim, achieved the collective goal of 1 million steps to increase the impact of the campaign.
Continue reading Dubai Miracle Garden Blooms with Hope as Boehringer Ingelheim Concludes Interstitial Lung Disease Awareness Campaign →